Myocarditis

Published 9 July 2021

A statement from the WHO Global Advisory Committee on Vaccine Safety on 9 July 2021 noted that clinicians need to be aware of the risks of myocarditis and pericarditis following mRNA vaccination and those most likely to be affected. Presentation includes acute chest pain, shortness of breath and palpitations, especially in young males.

Read more on the Immunisation Advisory Centre website.